FDA eyes new diabetes end points.
Katie
K
Kingwell
D015415:Biomarkers / Q000097:blood; D002986:Clinical Trials as Topic / Q000379:methods; D003920:Diabetes Mellitus / Q000097:blood* / Q000175:diagnosis / Q000453:epidemiology; D023381:Endpoint Determination / Q000379:methods / Q000639:trends*; D006442:Glycated Hemoglobin / Q000378:metabolism; D006801:Humans; D014481:United States / Q000453:epidemiology; D014486:United States Food and Drug Administration / Q000331:legislation & jurisprudence / Q000639:trends*
D015415:Biomarkers; D006442:Glycated Hemoglobin; C517652:hemoglobin A1c protein, human